Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03007953 · ClinicalTrials.gov registry record · NA

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
151
Enrollment target

NCT03007953: Completed NA study, sponsored by VA Office of Research and Development.

NCT03007953 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 151 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03007953, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
151 participants
Enrollment target

Study Summary

The focus of the study is to test a nurse-led telephone-based palliative care intervention on improving the delivery of care for patients with newly diagnosed lung cancer. The study is a three site randomized control trial to determine the efficacy of the intervention on improving patients' quality of life, symptom burden, and satisfaction of care. Additionally, the study will test an innovative care delivery model to improve patients' access to palliative care. The investigators will also determine the effect of the intervention on patient activation to discuss treatment preferences with their clinician and on clinician knowledge of patients' goals of care.

Interventions

  • BEHAVIORAL Palliative Care

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2016-12-05
Est. Completion 2019-12-11
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03007953

The ClinicalTrials.gov registry entry for NCT03007953 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Palliative Care is the first listed.

NCT03007953 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03007953 about?

NCT03007953 is a clinical study titled "Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II". The focus of the study is to test a nurse-led telephone-based palliative care intervention on improving the delivery of care for patients with newly diagnosed lung cancer. The study is a three site randomized control trial to determine the efficacy of the intervention on improving patients' quality ...

What is the current status of trial NCT03007953?

This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2016-12-05. Estimated completion is 2019-12-11.

What interventions are being tested in trial NCT03007953?

The interventions under investigation include: Palliative Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03007953?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.